Jianwei Wang
About
In The Last Decade
Jianwei Wang
604 papers receiving 16.7k citations
Hit Papers
Peers
Comparison fields: 5 of 198
- Molecular Biology 6.2k
- Infectious Diseases 5.7k
- Epidemiology 2.7k
- Immunology 2.5k
- Cardiology and Cardiovascular Medicine 1.9k
Countries citing papers authored by Jianwei Wang
This map shows the geographic impact of Jianwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianwei Wang more than expected).
Fields of papers citing papers by Jianwei Wang
This network shows the impact of papers produced by Jianwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianwei Wang. The network helps show where Jianwei Wang may publish in the future.
Co-authorship network of co-authors of Jianwei Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Jianwei Wang. A scholar is included among the top collaborators of Jianwei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianwei Wang. Jianwei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 31 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 32 | |
| 9 | 8 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 6 | |
| 14 | 5 | |
| 15 | 14 | |
| 16 | CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1 | 5 |
| 17 | Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer | 1 |
| 18 | Further Study of Circulating Antibodies to P16, CD25 and FOXP3 in Hepatocellular Carcinoma | 0 |
| 19 | 2 | |
| 20 | 51 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.